Report Detail

Request for Sample of this report

Other Global AI Biomedicine Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4672603
    • |
  • 16 February, 2026
    • |
  • Global
    • |
  • 103 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global AI Biomedicine Service market size was valued at US$ 4253 million in 2025 and is forecast to a readjusted size of US$ 7704 million by 2032 with a CAGR of 8.8% during review period.
AI biomedicine service represents the deep application of artificial intelligence technology in the biomedical field, aiming to accelerate new drug development, optimize disease diagnosis and treatment plans through advanced technologies such as big data analysis and machine learning. This service encompasses multiple aspects, from drug discovery and clinical trial design to patient management, significantly improving the efficiency and accuracy of biomedical research and development. By deeply mining massive medical data, ai can identify potential biomarkers, predict disease progression, and provide personalized treatment plans for patients. Additionally, ai assists doctors in diagnosing complex diseases, reducing misdiagnosis rates, and enhancing the quality of medical services. With continuous technological advancements, ai biomedicine service is gradually transforming the landscape of the biomedical industry, bringing more health benefits to patients.
From a multi-dimensional classification and parameterization perspective, the market can be segmented by service focus (AI drug discovery, AI antibody/biologic discovery, AI pathology and biomarker services, AI omics analytics), by delivery model (platform-as-a-service, fee-for-service, co-development partnerships, or risk-sharing milestone models), and by data modality (chemical structures, protein structures, imaging pathology data, genomics, transcriptomics, and multi-omics). Key performance parameters used by customers include hit identification success rates, lead optimization cycles, reduction in wet-lab iterations, model generalizability across targets, and the ability to integrate proprietary datasets securely.
The industry value chain begins upstream with data generation sources such as high-throughput screening labs, biobanks, sequencing providers, and pathology laboratories, alongside cloud and computing infrastructure suppliers. Midstream players are AI Biomedicine Service providers that combine proprietary algorithms, curated datasets, and domain expertise to deliver discovery or analysis services. Downstream customers include pharmaceutical companies, biotech startups, and, increasingly, CROs and CDMOs integrating AI into their service portfolios. Strategic partnerships and long-term collaborations are common, often embedding AI services deeply into clients’ R&D workflows.
From a profitability perspective, AI Biomedicine Services generally exhibit attractive gross margins, typically in the 60–80% range, reflecting their software- and data-driven nature. Margins vary by model: platform subscriptions and recurring service contracts achieve higher margins, while project-based discovery services see lower margins due to scientific labor and validation costs. Market momentum is driven by rising R&D costs, pressure to improve pipeline productivity, and growing acceptance of AI-derived insights by regulators and pharma partners. Key trends include consolidation between AI platforms and CROs, expansion from discovery into preclinical and translational stages, and increasing use of outcome-linked and co-development revenue models.
This report is a detailed and comprehensive analysis for global AI Biomedicine Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Biomedicine Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Biomedicine Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Biomedicine Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Biomedicine Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Biomedicine Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Biomedicine Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcellera Biologics, Evotec, Atomwise, XtalPi, PathAI, Paige AI, HotSpot Therapeutics, Scorpion Therapeutics, Charm Therapeutics, LifeMine Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Biomedicine Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
AI-driven Drug Discovery Services
AI-based Preclinical Research Services
AI-enabled Clinical Trial Services
AI Biomarker & Companion Diagnostic Services
Others
Market segment by Data Type & Modality
Genomics & Multi-omics AI Services
Medical Imaging & Digital Pathology AI Services
Chemical & Molecular Structure AI Services
Clinical & EHR Data AI Services
Others
Market segment by Service Delivery Model
Project-based AI Research Services
Subscription-based AI Platforms (Service Mode)
AI-as-a-Service (API / Cloud-based)
Others
Market segment by Application
Pharmaceutical & Biotech Companies
CRO / CDMO-oriented Companies
Academic & Research Institutes
Others
Market segment by players, this report covers
Abcellera Biologics
Evotec
Atomwise
XtalPi
PathAI
Paige AI
HotSpot Therapeutics
Scorpion Therapeutics
Charm Therapeutics
LifeMine Therapeutics
C4XD Discovery
Wave Life Sciences
Westlake Omics
IIpharma
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Biomedicine Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Biomedicine Service, with revenue, gross margin, and global market share of AI Biomedicine Service from 2021 to 2026.
Chapter 3, the AI Biomedicine Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Biomedicine Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Biomedicine Service.
Chapter 13, to describe AI Biomedicine Service research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AI Biomedicine Service by Type
    • 1.3.1 Overview: Global AI Biomedicine Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global AI Biomedicine Service Consumption Value Market Share by Type in 2025
    • 1.3.3 AI-driven Drug Discovery Services
    • 1.3.4 AI-based Preclinical Research Services
    • 1.3.5 AI-enabled Clinical Trial Services
    • 1.3.6 AI Biomarker & Companion Diagnostic Services
    • 1.3.7 Others
  • 1.4 Classification of AI Biomedicine Service by Data Type & Modality
    • 1.4.1 Overview: Global AI Biomedicine Service Market Size by Data Type & Modality: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global AI Biomedicine Service Consumption Value Market Share by Data Type & Modality in 2025
    • 1.4.3 Genomics & Multi-omics AI Services
    • 1.4.4 Medical Imaging & Digital Pathology AI Services
    • 1.4.5 Chemical & Molecular Structure AI Services
    • 1.4.6 Clinical & EHR Data AI Services
    • 1.4.7 Others
  • 1.5 Classification of AI Biomedicine Service by Service Delivery Model
    • 1.5.1 Overview: Global AI Biomedicine Service Market Size by Service Delivery Model: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global AI Biomedicine Service Consumption Value Market Share by Service Delivery Model in 2025
    • 1.5.3 Project-based AI Research Services
    • 1.5.4 Subscription-based AI Platforms (Service Mode)
    • 1.5.5 AI-as-a-Service (API / Cloud-based)
    • 1.5.6 Others
  • 1.6 Global AI Biomedicine Service Market by Application
    • 1.6.1 Overview: Global AI Biomedicine Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Pharmaceutical & Biotech Companies
    • 1.6.3 CRO / CDMO-oriented Companies
    • 1.6.4 Academic & Research Institutes
    • 1.6.5 Others
  • 1.7 Global AI Biomedicine Service Market Size & Forecast
  • 1.8 Global AI Biomedicine Service Market Size and Forecast by Region
    • 1.8.1 Global AI Biomedicine Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global AI Biomedicine Service Market Size by Region, (2021-2032)
    • 1.8.3 North America AI Biomedicine Service Market Size and Prospect (2021-2032)
    • 1.8.4 Europe AI Biomedicine Service Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific AI Biomedicine Service Market Size and Prospect (2021-2032)
    • 1.8.6 South America AI Biomedicine Service Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa AI Biomedicine Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Abcellera Biologics
    • 2.1.1 Abcellera Biologics Details
    • 2.1.2 Abcellera Biologics Major Business
    • 2.1.3 Abcellera Biologics AI Biomedicine Service Product and Solutions
    • 2.1.4 Abcellera Biologics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abcellera Biologics Recent Developments and Future Plans
  • 2.2 Evotec
    • 2.2.1 Evotec Details
    • 2.2.2 Evotec Major Business
    • 2.2.3 Evotec AI Biomedicine Service Product and Solutions
    • 2.2.4 Evotec AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Evotec Recent Developments and Future Plans
  • 2.3 Atomwise
    • 2.3.1 Atomwise Details
    • 2.3.2 Atomwise Major Business
    • 2.3.3 Atomwise AI Biomedicine Service Product and Solutions
    • 2.3.4 Atomwise AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Atomwise Recent Developments and Future Plans
  • 2.4 XtalPi
    • 2.4.1 XtalPi Details
    • 2.4.2 XtalPi Major Business
    • 2.4.3 XtalPi AI Biomedicine Service Product and Solutions
    • 2.4.4 XtalPi AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 XtalPi Recent Developments and Future Plans
  • 2.5 PathAI
    • 2.5.1 PathAI Details
    • 2.5.2 PathAI Major Business
    • 2.5.3 PathAI AI Biomedicine Service Product and Solutions
    • 2.5.4 PathAI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 PathAI Recent Developments and Future Plans
  • 2.6 Paige AI
    • 2.6.1 Paige AI Details
    • 2.6.2 Paige AI Major Business
    • 2.6.3 Paige AI AI Biomedicine Service Product and Solutions
    • 2.6.4 Paige AI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Paige AI Recent Developments and Future Plans
  • 2.7 HotSpot Therapeutics
    • 2.7.1 HotSpot Therapeutics Details
    • 2.7.2 HotSpot Therapeutics Major Business
    • 2.7.3 HotSpot Therapeutics AI Biomedicine Service Product and Solutions
    • 2.7.4 HotSpot Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 HotSpot Therapeutics Recent Developments and Future Plans
  • 2.8 Scorpion Therapeutics
    • 2.8.1 Scorpion Therapeutics Details
    • 2.8.2 Scorpion Therapeutics Major Business
    • 2.8.3 Scorpion Therapeutics AI Biomedicine Service Product and Solutions
    • 2.8.4 Scorpion Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Scorpion Therapeutics Recent Developments and Future Plans
  • 2.9 Charm Therapeutics
    • 2.9.1 Charm Therapeutics Details
    • 2.9.2 Charm Therapeutics Major Business
    • 2.9.3 Charm Therapeutics AI Biomedicine Service Product and Solutions
    • 2.9.4 Charm Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Charm Therapeutics Recent Developments and Future Plans
  • 2.10 LifeMine Therapeutics
    • 2.10.1 LifeMine Therapeutics Details
    • 2.10.2 LifeMine Therapeutics Major Business
    • 2.10.3 LifeMine Therapeutics AI Biomedicine Service Product and Solutions
    • 2.10.4 LifeMine Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 LifeMine Therapeutics Recent Developments and Future Plans
  • 2.11 C4XD Discovery
    • 2.11.1 C4XD Discovery Details
    • 2.11.2 C4XD Discovery Major Business
    • 2.11.3 C4XD Discovery AI Biomedicine Service Product and Solutions
    • 2.11.4 C4XD Discovery AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 C4XD Discovery Recent Developments and Future Plans
  • 2.12 Wave Life Sciences
    • 2.12.1 Wave Life Sciences Details
    • 2.12.2 Wave Life Sciences Major Business
    • 2.12.3 Wave Life Sciences AI Biomedicine Service Product and Solutions
    • 2.12.4 Wave Life Sciences AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Wave Life Sciences Recent Developments and Future Plans
  • 2.13 Westlake Omics
    • 2.13.1 Westlake Omics Details
    • 2.13.2 Westlake Omics Major Business
    • 2.13.3 Westlake Omics AI Biomedicine Service Product and Solutions
    • 2.13.4 Westlake Omics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Westlake Omics Recent Developments and Future Plans
  • 2.14 IIpharma
    • 2.14.1 IIpharma Details
    • 2.14.2 IIpharma Major Business
    • 2.14.3 IIpharma AI Biomedicine Service Product and Solutions
    • 2.14.4 IIpharma AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 IIpharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AI Biomedicine Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of AI Biomedicine Service by Company Revenue
    • 3.2.2 Top 3 AI Biomedicine Service Players Market Share in 2025
    • 3.2.3 Top 6 AI Biomedicine Service Players Market Share in 2025
  • 3.3 AI Biomedicine Service Market: Overall Company Footprint Analysis
    • 3.3.1 AI Biomedicine Service Market: Region Footprint
    • 3.3.2 AI Biomedicine Service Market: Company Product Type Footprint
    • 3.3.3 AI Biomedicine Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AI Biomedicine Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global AI Biomedicine Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global AI Biomedicine Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global AI Biomedicine Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America AI Biomedicine Service Consumption Value by Type (2021-2032)
  • 6.2 North America AI Biomedicine Service Market Size by Application (2021-2032)
  • 6.3 North America AI Biomedicine Service Market Size by Country
    • 6.3.1 North America AI Biomedicine Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico AI Biomedicine Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe AI Biomedicine Service Consumption Value by Type (2021-2032)
  • 7.2 Europe AI Biomedicine Service Consumption Value by Application (2021-2032)
  • 7.3 Europe AI Biomedicine Service Market Size by Country
    • 7.3.1 Europe AI Biomedicine Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 7.3.3 France AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy AI Biomedicine Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific AI Biomedicine Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific AI Biomedicine Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific AI Biomedicine Service Market Size by Region
    • 8.3.1 Asia-Pacific AI Biomedicine Service Consumption Value by Region (2021-2032)
    • 8.3.2 China AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 8.3.5 India AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia AI Biomedicine Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America AI Biomedicine Service Consumption Value by Type (2021-2032)
  • 9.2 South America AI Biomedicine Service Consumption Value by Application (2021-2032)
  • 9.3 South America AI Biomedicine Service Market Size by Country
    • 9.3.1 South America AI Biomedicine Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina AI Biomedicine Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa AI Biomedicine Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa AI Biomedicine Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa AI Biomedicine Service Market Size by Country
    • 10.3.1 Middle East & Africa AI Biomedicine Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia AI Biomedicine Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE AI Biomedicine Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 AI Biomedicine Service Market Drivers
  • 11.2 AI Biomedicine Service Market Restraints
  • 11.3 AI Biomedicine Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 AI Biomedicine Service Industry Chain
  • 12.2 AI Biomedicine Service Upstream Analysis
  • 12.3 AI Biomedicine Service Midstream Analysis
  • 12.4 AI Biomedicine Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on AI Biomedicine Service. Industry analysis & Market Report on AI Biomedicine Service is a syndicated market report, published as Global AI Biomedicine Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of AI Biomedicine Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo